Nicholas Hoffman & Company’s CME Group CME Stock Holding History

Nicholas Hoffman & Company’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-899	Closed	-$246K	–	331
2025 Q4	$246K	Buy	+899	New	+$244K	0.01%	291

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nicholas Hoffman & Company's CME Position: Q1 2026 in Review

Nicholas Hoffman & Company sold out of CME Group (CME) in Q1 2026, closing a stake of 899 shares — an estimated $246K sold.

Nicholas Hoffman & Company first reported a position in CME in Q4 2025 and held it in 1 quarter. The position peaked at $246K in Q4 2025. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Nicholas Hoffman & Company reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Nicholas Hoffman & Company sold 899 CME Group shares in Q1 2026, an estimated $246K.
Nicholas Hoffman & Company first reported a position in CME Group in Q4 2025 and held it in 1 quarter.
Nicholas Hoffman & Company's CME Group position peaked at $246K in Q4 2025.
1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q1 2026, filed 29 Apr 2026.